ATE294168T1 - Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten - Google Patents
Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivatenInfo
- Publication number
- ATE294168T1 ATE294168T1 AT02779576T AT02779576T ATE294168T1 AT E294168 T1 ATE294168 T1 AT E294168T1 AT 02779576 T AT02779576 T AT 02779576T AT 02779576 T AT02779576 T AT 02779576T AT E294168 T1 ATE294168 T1 AT E294168T1
- Authority
- AT
- Austria
- Prior art keywords
- trans
- preparation
- cyclohepta
- dibenzo
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204961 | 2001-12-07 | ||
| PCT/EP2002/013560 WO2003048146A1 (en) | 2001-12-07 | 2002-12-02 | PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE294168T1 true ATE294168T1 (de) | 2005-05-15 |
Family
ID=8181460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779576T ATE294168T1 (de) | 2001-12-07 | 2002-12-02 | Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6998494B2 (de) |
| EP (1) | EP1456193B1 (de) |
| JP (1) | JP4516752B2 (de) |
| KR (1) | KR20050044329A (de) |
| CN (1) | CN1293066C (de) |
| AT (1) | ATE294168T1 (de) |
| AU (1) | AU2002342926B2 (de) |
| BR (1) | BR0214068A (de) |
| CA (1) | CA2468038C (de) |
| DE (1) | DE60203937T2 (de) |
| ES (1) | ES2242076T3 (de) |
| HK (1) | HK1076461A1 (de) |
| HR (1) | HRP20040490A2 (de) |
| HU (1) | HUP0402152A3 (de) |
| IL (1) | IL162349A0 (de) |
| MX (1) | MXPA04005400A (de) |
| NO (1) | NO20042884L (de) |
| NZ (1) | NZ532806A (de) |
| PL (1) | PL369585A1 (de) |
| WO (1) | WO2003048146A1 (de) |
| ZA (1) | ZA200404394B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2468038C (en) * | 2001-12-07 | 2011-04-26 | Janssen Pharmaceutica Nv | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
| AU2005251948A1 (en) * | 2004-06-14 | 2005-12-22 | Janssen Pharmaceutica N.V. | Novel tetracyclic tetrahydrofuran derivatives |
| CN100591652C (zh) * | 2004-08-31 | 2010-02-24 | 詹森药业有限公司 | 生产2-（4-氟-苄基）-苯基-乙酸的方法 |
| RU2401257C2 (ru) | 2004-12-07 | 2010-10-10 | Янссен Фармацевтика Н.В. | Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена |
| JP4937141B2 (ja) | 2005-01-27 | 2012-05-23 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｎｓ障害の処置における５ｈｔ２インヒビターとしての複素環式四環式テトラヒドロフラン誘導体 |
| ES2342110T3 (es) | 2005-06-17 | 2010-07-01 | Janssen Pharmaceutica Nv | Nuevos derivados tetraciclicos de tetrahidrofurano que contienen una cadena lateral de amina ciclica. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9901613A3 (en) | 1996-04-12 | 2001-08-28 | Janssen Pharmaceutica Nv | Substituted tetracyclic fused furanamine derivatives, process for their preparation, use thereof and pharmaceutical compositions containing them |
| UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| CA2468038C (en) * | 2001-12-07 | 2011-04-26 | Janssen Pharmaceutica Nv | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| PL370440A1 (en) * | 2001-12-07 | 2005-05-30 | Janssen Pharmaceutica N.V. | Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
-
2002
- 2002-12-02 CA CA2468038A patent/CA2468038C/en not_active Expired - Fee Related
- 2002-12-02 DE DE60203937T patent/DE60203937T2/de not_active Expired - Lifetime
- 2002-12-02 HU HU0402152A patent/HUP0402152A3/hu unknown
- 2002-12-02 KR KR1020047005553A patent/KR20050044329A/ko not_active Application Discontinuation
- 2002-12-02 JP JP2003549337A patent/JP4516752B2/ja not_active Expired - Fee Related
- 2002-12-02 PL PL02369585A patent/PL369585A1/xx not_active Application Discontinuation
- 2002-12-02 IL IL16234902A patent/IL162349A0/xx not_active IP Right Cessation
- 2002-12-02 NZ NZ532806A patent/NZ532806A/en unknown
- 2002-12-02 EP EP02779576A patent/EP1456193B1/de not_active Expired - Lifetime
- 2002-12-02 BR BR0214068-3A patent/BR0214068A/pt not_active Withdrawn
- 2002-12-02 CN CNB028244885A patent/CN1293066C/zh not_active Expired - Fee Related
- 2002-12-02 ES ES02779576T patent/ES2242076T3/es not_active Expired - Lifetime
- 2002-12-02 US US10/496,279 patent/US6998494B2/en not_active Expired - Fee Related
- 2002-12-02 AU AU2002342926A patent/AU2002342926B2/en not_active Ceased
- 2002-12-02 MX MXPA04005400A patent/MXPA04005400A/es active IP Right Grant
- 2002-12-02 AT AT02779576T patent/ATE294168T1/de not_active IP Right Cessation
- 2002-12-02 WO PCT/EP2002/013560 patent/WO2003048146A1/en active IP Right Grant
-
2004
- 2004-05-31 HR HR20040490A patent/HRP20040490A2/hr not_active Application Discontinuation
- 2004-06-03 ZA ZA200404394A patent/ZA200404394B/en unknown
- 2004-07-07 NO NO20042884A patent/NO20042884L/no not_active Application Discontinuation
-
2005
- 2005-05-31 US US11/141,612 patent/US20050228043A1/en not_active Abandoned
- 2005-09-23 HK HK05108415A patent/HK1076461A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20040490A2 (en) | 2004-10-31 |
| JP2005511691A (ja) | 2005-04-28 |
| AU2002342926B2 (en) | 2009-02-26 |
| NO20042884L (no) | 2004-07-07 |
| WO2003048146A1 (en) | 2003-06-12 |
| NZ532806A (en) | 2006-01-27 |
| EP1456193A1 (de) | 2004-09-15 |
| BR0214068A (pt) | 2004-10-13 |
| US6998494B2 (en) | 2006-02-14 |
| ES2242076T3 (es) | 2005-11-01 |
| AU2002342926A1 (en) | 2003-06-17 |
| US20050228043A1 (en) | 2005-10-13 |
| HK1076461A1 (en) | 2006-01-20 |
| CA2468038A1 (en) | 2003-06-12 |
| US20050014820A1 (en) | 2005-01-20 |
| IL162349A0 (en) | 2005-11-20 |
| DE60203937T2 (de) | 2006-05-11 |
| HUP0402152A3 (en) | 2007-03-28 |
| HUP0402152A2 (hu) | 2005-02-28 |
| CN1293066C (zh) | 2007-01-03 |
| EP1456193B1 (de) | 2005-04-27 |
| ZA200404394B (en) | 2005-09-05 |
| DE60203937D1 (de) | 2005-06-02 |
| CA2468038C (en) | 2011-04-26 |
| MXPA04005400A (es) | 2004-10-11 |
| CN1602306A (zh) | 2005-03-30 |
| PL369585A1 (en) | 2005-05-02 |
| JP4516752B2 (ja) | 2010-08-04 |
| KR20050044329A (ko) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1076461A1 (en) | Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives | |
| HUP9701048A2 (hu) | Új eljárás sildenafil előállítására és a felhasznált új köztitermékek | |
| SE0102616D0 (sv) | Novel compounds | |
| AR031248A1 (es) | Compuestos de ditosilato de quinazolina, composicion farmaceutica, metodo de tratamiento y uso en terapia y proceso para la preparacion de dichos compuestos | |
| NZ522568A (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
| AR018693A1 (es) | MÉTODO PARA LA PREPARACIoN DE CITALOPRAM Y COMPUESTOS INTERMEDIARIOS PARA USO EN DICHO MÉTODO. | |
| DE60218048D1 (de) | Thiophenverbindungen als arzneimittel | |
| TNSN07485A1 (fr) | Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| NO20023405D0 (no) | Fremgangsmåte for fremstilling av 5-Cyanoftalid | |
| MXPA04005399A (es) | Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano. | |
| PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
| HUP0301942A2 (hu) | Eljárás citalopram elżállítására | |
| EA200001101A1 (ru) | НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| MXPA04003278A (es) | Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina. | |
| ATE284882T1 (de) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
| EP1211253A4 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
| BG106846A (en) | Novel heteroaryl derivatives, their preparation and use | |
| EE200300058A (et) | Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel | |
| BG106971A (en) | Method for the preparation of 5-cyanophthalide | |
| EP1148059A4 (de) | Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
| FI104078B (fi) | Menetelmä terapeuttisesti käyttökelpoisten (3-(1-piperatsinyyli)tieno£2,3-b|- ja -£2,3-c|pyridiinijohdannaisten valmistamiseksi | |
| DK1490391T3 (da) | 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1456193 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |